Cited by 321Semantic Web and OntologiesBiomedical Text Mining and OntologiesComputational Drug Discovery Methods

Open PHACTS: semantic interoperability for drug discovery

Open access
Williams, Antony J., Harland, Lee, Groth, Paul, Pettifer, Stephen, Chichester, Christine, Willighagen, Egon L., Evelo, Chris T., Blomberg, Niklas +3 more·2012·Drug Discovery Today

Abstract

Open PHACTS is a public-private partnership between academia, publishers, small and medium sized enterprises and pharmaceutical companies. The goal of the project is to deliver and sustain an 'open pharmacological space' using and enhancing state-of-the-art semantic web standards and technologies. It is focused on practical and robust applications to solve specific questions in drug discovery research. OPS is intended to facilitate improvements in drug discovery in academia and industry and to support open innovation and in-house non-public drug discovery research. This paper lays out the challenges and how the Open PHACTS project is hoping to address these challenges technically and socially.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2012.05.016

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The growth of the CC resource is restricted by the number and quality of publicly accessible data sets.

    “The growth of the CC resource is restricted by the number and quality of publicly accessible data sets, a limitation that is likely to be ameliorated with the implementation of private-public partnerships and the general awareness that, in the markedly gene-centric omics era, the depth of small-molecule annotation lags behind genomes and proteomes39,40.”
  • The depth of small-molecule annotation lags behind genomes and proteomes.

    “the depth of small-molecule annotation lags behind genomes and proteomes39,40.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Williams, A. J., Harland, L., Groth, P., Pettifer, S., Chichester, C., Willighagen, E. L., Evelo, C. T., Blomberg, N., Ecker, G., Goble, C., & Mons, B.
Affiliations
  • Royal Society of Chemistry (GB)
  • Vrije Universiteit Amsterdam (NL)
  • SIB Swiss Institute of Bioinformatics (CH)
  • Maastricht University (NL)
  • Leiden University Medical Center (NL)
  • AstraZeneca (Sweden) (SE)
  • University of Vienna (AT)
  • University of Manchester (GB)
Corresponding author
Williams, Antony J.
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2012-11
Volume
17
Issue
21-22
Pages
1188-1198
ISSN
1359-6446 (ISSN-L)
OpenAlex
W2116238734
Cited by
321
References
51
Citations by year
2026: 6 · 2025: 4 · 2024: 8 · 2023: 11 · 2022: 10 · 2021: 15 · 2020: 13 · 2019: 25 · 2018: 22 · 2017: 30 · 2016: 45 · 2015: 48 · 2014: 48 · 2013: 24 · 2012: 12
FWCI
11.84
Type
journal article
Language
en
Open access
Locations
  • Drug Discovery Today (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics
  • Physical Sciences › Computer Science › Artificial Intelligence › Semantic Web and Ontologies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biomedical Text Mining and Ontologies
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
Keywords
Open PHACTS, semantic interoperability, semantic web, drug discovery, public-private partnerships, open innovation
MeSH terms
Drug Industry, Humans, Organizational Innovation, Research, Semantics, Drug Design, Information Storage and Retrieval, Internet, Drug Discovery, Public-Private Sector Partnerships

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review